Please join us for the 5th Annual Bay Area Lifesciences Roundtable, this year featuring four weekly virtual sessions, each addressing cutting-edge trends and hot topics.
Recordings and materials from previous sessions can also be found below.
WHO MAY BE INTERESTED IN ATTENDING
Executives, Investors, General Counsel and Company Counsel
Artificial Intelligence in Regulated Industries: Comparing Experiences in the Life Sciences and Financial Sectors
Tuesday, June 30, 2020
11:00 a.m. PT | 1:00 p.m. CT | 2:00 p.m. ET
Artificial intelligence and machine learning are driving innovation across industries and, in particular, in the life sciences. Will these technologies be the subject of targeted regulation? And if so, how? The FDA, among others, has acknowledged that the traditional paradigm for regulating devices was not designed with these technologies in mind. We will discuss what we can learn by comparing regulators’ approaches to these technologies across these two highly regulated sectors as well as how might they develop differently and how innovation might shape the law in this area and vice versa.
SPEAKERS:
DAVID SHAYWITZ, MD, PHD, Founder, Astounding HealthTech
NATHAN GREENE, Partner, Sidley
KATE HEINZELMAN, Partner, Sidley
Looking Ahead: Telehealth and Patient Engagement Platforms
Friday, June 26, 2020
1:00 p.m. PT | 3:00 p.m. CT | 4:00 p.m. ET
Investors and drug developers are increasingly evaluating health tech strategy as a way to promote patient access and continuity of care or therapy. This panel will discuss opportunities available to start-ups and investors in light of current and potential future reforms to support expanded access to telehealth services. We will also discuss the importance of technology-based patient engagement tools to support medication adherence, patient education and patient assistance.
SPEAKERS:
TERESIA BOST, General Counsel, Quartet Health
MEENA DATTA, Partner, Sidley
DONIELLE MCCUTCHEON, Partner, Sidley
Life Sciences Dealmaking in the Time of COVID-19
Friday, June 12, 2020
1:00 p.m. PT | 3:00 p.m. CT | 4:00 p.m. ET
The COVID-19 crisis presents both challenges and opportunities for life sciences companies and investors. This panel will discuss various ways that private and public companies are raising capital and the terms that investors are seeking. We will discuss PIPEs, reverse mergers, “down rounds,” “pay to play” provisions and other terms that are experiencing a resurgence among dealmakers.
SPEAKERS:
ROB CARLSON, Partner, Sidley
MEHDI KHODADAD, Partner, Sidley
How COVID-19 Has Transformed the Way FDA Regulates—And What Regulated Industry and the Public Expect Going Forward
Friday, May 29, 2020
1:00 p.m. PT | 3:00 p.m. CT | 4:00 p.m. ET
FDA has moved at record speed to respond to the needs of the COVID-19 pandemic—issuing immediate guidance on a range of topics, Emergency Use Authorizations (EUAs), and going outside of its comfort zone to consider new ways to utilize real-world evidence and alternative trial designs. We will explore what these developments mean for regulated industry, including implications for clinical study, pathways to approval and potential exclusivity.
SPEAKERS:
BECKY WOOD, Partner, Sidley
EMILY MARDEN, Counsel, Sidley
Sidley Austin LLP is an accredited MCLE provider in IL, NY and CA.
For questions, contact sfevents@sidley.com.
